Bionano Genomics Affirms FY2026 Sales Guidance of $31.000M-$33.000M vs $32.474M Est
Benzinga Newsdesk 10 hours ago
NewsGuidance
Bionano Genomics (NASDAQ:BNGO) affirms FY2026 sales outlook from $31.000 million-$33.000 million to $31.000 million-$33.000 million vs $32.474 million estimate.
Bionano Genomics (NASDAQ:BNGO) affirms FY2026 sales outlook from $31.000 million-$33.000 million to $31.000 million-$33.000 million vs $32.474 million estimate.